DS
QGENF

David Shaw’s QIAGEN NV QGENF Stock Holding History

David Shaw’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-729,597
Closed -$20.4M – 3836
2016
Q4 		$20.4M Buy
729,597
+390,877
+115% +$11M 0.03% 613
2016
Q3 		$9.3M Sell
338,720
-6,129
-2% -$168K 0.02% 930
2016
Q2 		$7.51M Sell
344,849
-507,370
-60% -$11.1M 0.01% 1054
2016
Q1 		$19M Buy
852,219
+792,753
+1,333% +$17.7M 0.03% 558
2015
Q4 		$1.63M Buy
59,466
+2,429
+4% +$66.7K ﹤0.01% 2288
2015
Q3 		$1.47M Sell
57,037
-36,936
-39% -$951K ﹤0.01% 2321
2015
Q2 		$2.31M Sell
93,973
-33,615
-26% -$827K ﹤0.01% 2074
2015
Q1 		$3.22M Sell
127,588
-89,761
-41% -$2.26M ﹤0.01% 1689
2014
Q4 		$5.09M Buy
217,349
+100,627
+86% +$2.36M 0.01% 1555
2014
Q3 		$2.66M Buy
+116,722
New +$2.66M ﹤0.01% 2016
2014
Q2 		– Sell
-86,930
Closed -$1.83M – 4918
2014
Q1 		$1.83M Buy
86,930
+37,528
+76% +$789K ﹤0.01% 2482
2013
Q4 		$1.15M Sell
49,402
-1,448
-3% -$33.7K ﹤0.01% 3040
2013
Q3 		$1.09M Buy
50,850
+37,480
+280% +$807K ﹤0.01% 2959
2013
Q2 		$263K Buy
+13,370
New +$263K ﹤0.01% 3644

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.7B AUM 32.92% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

David Shaw's QGENF Position: Q1 2017 in Review

David Shaw sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 729,597 shares — an estimated $20.4M sold.

David Shaw first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $20.4M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • David Shaw reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • David Shaw sold 729,597 QIAGEN NV shares in Q1 2017, an estimated $20.4M.
  • David Shaw first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • David Shaw's QIAGEN NV position peaked at $20.4M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.